Literature DB >> 30527835

Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.

Temeka Zore1, Daria Lizneva2, Soumia Brakta3, Walidah Walker3, Larisa Suturina4, Ricardo Azziz5.   

Abstract

OBJECTIVE: To test the hypothesis that the polycystic ovary syndrome (PCOS) phenotype, or its component features, is less severe in adolescents than in young adult patients, in a referred (clinical) population.
DESIGN: Cross-sectional study.
SETTING: Tertiary-care academic medical center. PATIENT(S): Two hundred seventy-four adolescents and young adults aged 13.0-24.9 years with PCOS according to the National Institute of Health 1990 criteria. Patients were categorized as adolescents (AD: 13.0-18.9 years; n = 91) and young adults (YA: 19.0-24.9 years; n = 183). Adolescents were further categorized as early adolescents (Early-AD: 13.0-15.9 years; n = 31) and late adolescents (Late-AD: 16.0-18.9 years; n = 60). INTERVENTION(S): History, physical examination, hormonal assays with the use of standardized protocols. MAIN OUTCOME MEASURE(S): Unadjusted and adjusted odds ratios (ORs; adjusted for body mass index [BMI] when applicable) were calculated for biochemical hyperandrogenism (HA), hirsutism (HIR), acne, and degree of oligo/amenorrhea (OA). PCOS phenotypes were classified as HIR+HA+OA, HA+OA, and HIR+OA. RESULT(S): Our analysis demonstrated minimal significant difference in the prevalence of the three PCOS phenotypes, or component features, between AD and YA patients. The risks for obesity were higher for YA versus AD, and the risk of acne was lower for YA versus AD. There was no significant difference between Early-AD and Late-AD. BMI-adjusted models did not significantly modify the main findings. CONCLUSION(S): The present study suggests that the PCOS phenotype is established in early adolescence, remains constant into adulthood, and is not related to BMI.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PCOS; adolescents; obesity; phenotypes

Mesh:

Substances:

Year:  2018        PMID: 30527835     DOI: 10.1016/j.fertnstert.2018.10.020

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Ovarian follicle count by magnetic resonance imaging is greater in adolescents and young adults with polycystic ovary syndrome than in controls.

Authors:  Camila Freitas Pereira-Eshraghi; Rachel Tao; Codruta C Chiuzan; Yuan Zhang; Wei Shen; Jodi P Lerner; Sharon E Oberfield; Aviva B Sopher
Journal:  F S Rep       Date:  2022-02-02

2.  ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome.

Authors:  Donna F Vine; Lawrence J Beilin; Sally Burrows; Rae-Chi Huang; Martha Hickey; Roger Hart; Spencer D Proctor; Trevor A Mori
Journal:  J Endocr Soc       Date:  2020-05-26

3.  Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome.

Authors:  Sebastião Freitas de Medeiros; Matheus Antônio Souto de Medeiros; Bruna Barcelo Barbosa; Márcia Marly Winck Yamamoto; Gustavo Arantes Rosa Maciel
Journal:  Arch Gynecol Obstet       Date:  2020-11-17       Impact factor: 2.344

4.  Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.

Authors:  Enrico Carmina; Brigitte Dreno; W Anne Lucky; W George Agak; Anuja Dokras; Jin Ju Kim; Rogerio A Lobo; Fahimeh Ramezani Tehrani; Daniel Dumesic
Journal:  J Endocr Soc       Date:  2022-02-06

Review 5.  Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review.

Authors:  Alexia S Peña; Ethel Codner; Selma Witchel
Journal:  Diagnostics (Basel)       Date:  2022-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.